CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)
South Korea · Delayed Price · Currency is KRW
1,974.00
-36.00 (-1.79%)
At close: Feb 27, 2026
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 |
|---|
| 99.10B | 93.91B | 82.20B | 58.62B | 49.86B | | | | | |
| 5.53% | 14.25% | 40.21% | 17.56% | 20.05% | | | | | |
| 99.10B | 93.91B | 82.20B | 58.62B | 49.86B | | | | | |
| 5.53% | 14.25% | 40.21% | 17.56% | 20.05% | | | | | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 |
|---|
| 98.79B | 92.18B | 81.76B | 58.14B | 49.67B | | | | | |
| 7.18% | 12.75% | 40.62% | 17.06% | 20.28% | | | | | |
| 216.64M | 1.65B | 427.37M | - | - | | | | | |
| -86.83% | 285.03% | - | - | - | | | | | |
| 90.76M | 85.31M | 14.29M | 121.19M | 22.65M | | | | | |
| 6.38% | 497.05% | -88.21% | 435.04% | -54.31% | | | | | |
| - | - | - | - | 160.37M | | | | | |
| - | - | - | - | -14.96% | | | | | |
| - | - | - | 13.30M | 13.21M | | | | | |
| - | - | - | 0.63% | 186.40% | | | | | |
| - | - | - | 318.26M | - | | | | | |
| - | - | - | 10.35M | - | | | | | |
| - | - | - | 18.23M | - | | | | | |
| 99.10B | 93.91B | 82.20B | 58.62B | 49.86B | | | | | |
| 5.53% | 14.25% | 40.21% | 17.56% | 20.05% | | | | | |
Source: S&P Global Market Intelligence.